Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yukio Ohya is active.

Publication


Featured researches published by Yukio Ohya.


Biochimica et Biophysica Acta | 1993

Pro-major basic protein has three types of sugar chains at the pro-portion

Yasushi Shikata; Yuichiro Hayashi; Kentaro Yoshimatsu; Yukio Ohya; Toshio Seto; Komei Fukushima; Yutaka Yoshida

The amino-acid sequence of purified recombinant pro-major basic protein from Chinese hamster kidney cells was determined to verify the primary structure and glycosylation sites. Reduced and S-carboxamidemethylated protein was first digested with Achromobacter proteinase I. Each peptide was characterized by amino-acid analysis and amino-acid sequence analysis. We could identify all the peptides which were expected from the pro-major basic protein cDNA sequence. Sequence analysis and deglycosylation study revealed that Ser-8, Thr-9, Ser-46 and Asn-70 were glycosylated. The results indicated that proMBP has three types of sugar chains, O-glycoside, N-glycoside and glycosaminoglycan, in the pro-portion.


Biochemical Journal | 1998

Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain

Koji Sagane; Yukio Ohya; Yoshikazu Hasegawa; Isao Tanaka


Archive | 1989

Recombinant natural killer cell activator

Kentaro Yoshimatsu; Yukio Ohya; Yasushi Shikata; Isao Tanaka; Yoshikazu Hasegawa; Toshio Seto; Toshiaki Osawa


Archive | 1981

Cephalosporin compounds and antibacterial drugs containing the same

Yoshimasa Machida; Isao Saito; Seiichiro Nomoto; Shigeto Negi; Takeo Kanai; Kyosuke Kitoh; Kanemasa Katsu; Yukio Ohya; Takeshi Nagasu


Archive | 1980

Cephalosporin derivatives, and antibacterial drugs containing the derivatives

Yoshimasa Machida; Isao Saito; Motosuke Yamanaka; Seiichiro Nomoto; Shigeto Negi; Kyosuke Kitoh; Kanemasa Katsu; Yukio Ohya; Takeshi Suzuki; Kyoko Koizumi


Archive | 1989

Rekombinanter natürlicher Killerzellen-Aktivator. A recombinant natural killer cell activator.

Kentaro Yoshimatsu; Yukio Ohya; Yasushi Shikata; Isao Tanaka; Yoshikazu Hasegawa; Toshio Seto; Toshiaki Osawa


Archive | 1989

Recombinant Activator Foer naturliga doedarceller.

Kentaro Yoshimatsu; Yukio Ohya; Yasushi Shikata; Isao Tanaka; Yoshikazu Hasegawa; Toshio Seto; Toshiaki Osawa


Archive | 1980

DERIVATI DELLA CEFALOSPORINA, PROCEDIMENTI PER LA PREPARAZIONE DEGLI STESSI, E MEDICINALI ANTIBATTERICI CONTENENTI I LORO DERIVATI.

Yoshimasa Machida; Isao Saito; Motosuke Yamanaka; Seiichiro Nomoto; Shigeto Negi; Hironori Ikuta; Kyosuke Kitoh; Kanemasa Katsu; Yukio Ohya; Takeshi Suzuki


Archive | 1980

Cephalosporinverbindungen, verfahren zu deren herstellung und bakterizide arzneimittel, welche diese enthalten Cephalosporin compounds, processes for their preparation and bactericidal drugs which contain these

Yoshimasa Machida; Isao Saito; Seiichiro Nomoto; Shigeto Negi; Takeo Kanai; Kyosuke Kitoh; Kanemasa Katsu; Yukio Ohya; Takeshi Nagasu


Archive | 1980

Cephalosporin compounds, processes for the preparation thereof, and antibacterial drugs containing the same

Takeshi Nagasu; Isao Saito; Kyosuke Kitoh; Shigeto Negi; Yukio Ohya; Kanemasa Katsu; Yoshimasa Machida; Seiichiro Nomoto; Takeo Kanai

Researchain Logo
Decentralizing Knowledge